John Lunger, Chief Patient Supply Officer at Adaptimmune Therapeutics PLC (ADAP), sold 3,096 shares at $0.91 ($3K) on 2023-08-01, disclosed to the SEC on 2023-08-01.
Seasonal sale ($3k) by Chief Patient Supply Officer — this insider has traded ADAP in August in at least three consecutive prior years. Pattern-driven, low signal.
Negative factors outweigh the positive ones.
| Filing → |
| ADAP | SELL | 2024-01-17 | $16K | — | Filing → |
| ADAP | SELL | 2024-01-12 | $8K | — | Filing → |
| ADAP | SELL | 2023-01-17 | $8K | — | Filing → |